SeLux Diagnostics
PrivateLast Round
Series C
Extension
Apr 1, 2024
Total Funding Raised
$268.25M
Company Overview
SeLux Diagnostics is a biotechnology company that develops a rapid phenotyping platform for antibiotic susceptibility testing and the diagnosis of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SeLux Diagnostics Comparables
Compare SeLux Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PhAST Diagnostics | 89% | |
| First Light Diagnostics, Inc. | 88% | |
| Pattern Bioscience | 88% | |
SeLux Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Apr 1, 2024 | ||||
| Series C Extension | Feb 13, 2024 | ||||
| Grant | Jul 12, 2022 | ||||
| Debt | Jun 1, 2022 | ||||
| Series C | Feb 28, 2022 | ||||
Grant | Oct 19, 2021 |
Key People
Founding team and executive leadership
SeLux Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B, Series C, Series C Extension |
| NIH RADx | Grant |
| Northpond Ventures | Series C, Series B, Series C Extension |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Schooner Capital | Series C, Series B, Series C Extension |
| Biomedical Advanced Research and Development Authority | Grant |
| Oxford Finance | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2024
$48M round led by RA Capital Management.
- Feb 13, 2024
$48M round led by RA Capital Management.
SeLux Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SeLux Diagnostics's valuation, stock price, and market status.